JCI colloidal iodine

Please select the tabs below to view the information you require.

Colloidal iodine preparation [JCI MN Colloidal Iodine (C.I.M.N.)

In 2019, cancer accounted for 376,392 deaths by cause of death in Japan, and has been the leading cause of death since 1981, with approximately 1 in 2 people getting cancer and 1 in 3 people dying from it. This is followed by heart disease (207,628 deaths), senility (121,868 deaths), and cerebrovascular disease (106,506 deaths), with these top four diseases accounting for approximately 60% of all deaths.

However, no breakthrough treatment for cancer has yet been found.
In addition, many people suffer from intractable diseases whose causes are unknown and treatment methods have not yet been established.

Colloidal Iodine preparation (JCI MN Colloidal Iodine (C.I.M.N)) was developed to help many patients suffering from cancer and intractable diseases. JCI MN Colloidal Iodine® is the only colloidal iodine approved in the world by the Ministry of Ayurveda of the Democratic Socialist Republic of Sri Lanka. It is approved as a pharmaceutical product in Sri Lanka, but not approved in Japan, so it is an area of observational research.

We first began using the name "colloidal iodine" about 15 years ago, when we developed the world's first oral and intravenous solutions that allow iodine to be safely taken into the body.

Recently, there have been many cases in which "colloidal iodine" or iodine agents with similar names have been misleadingly advertised as "JCI colloidal iodine" as if they have the same effects as "JCI colloidal iodine," leading to many misunderstandings and causing problems. Our "Colloidal Iodine" is used in Japan and abroad under the names "JCI MN COLLOIDAL IODINE" and "JCI MN COLLOIDAL IODINE" (trademark registered).

JCI colloidal iodine

Comprehensive Medicine and Colloidal Iodine

In modern medicine, "symptomatic therapy" based on the expectation of medicinal effects of drugs is mainly practiced, but "fundamental therapy" or "causative therapy" that enhances our natural immunity and draws out our natural healing power is attracting attention. However, "root or causative therapy," which enhances the body's innate immunity and brings out its natural healing power, has been attracting attention.

JCI MN colloidal iodine (C.I.M.N.) is highly effective in activating metabolic functions, enhancing immunity and natural healing power, and acts to improve the following medical conditions

  • Various cancers including terminal cancer
  • Vascular disorders (brain, heart, etc.)
  • Autoimmune and allergic diseases
  • Viral diseases (including AIDS)
  • Epilepsy and other brain disorders
  • Diabetes mellitus, kidney disease
  • Other intractable diseases
  • In addition, it is expected to help maintain health and prevent disease.

Superior efficacy and safety

Many cancer patients (mostly terminal) and patients with other diseases have recovered dramatically with JCI MN Colloidal Iodine (C.I.M.N.).

In addition, there are few side effects as shown in the table below, and the safety of the treatment has been confirmed through 10 years of treatment experience.

Recently, more and more physicians have become interested in the efficacy of JCI MN Colloidal Iodine (C.I.M.N.) and its use by physicians and health care professionals has produced amazing recovery results in the treatment of cancer, vascular disorders, and other medical conditions.

Conventional Cancer Therapydemerit
surgeryThere is a possibility of recurrence if there are cancer cells elsewhere in the body with significant damage to the body.
chemotherapyAlone, it cannot cure the disease completely and is often associated with side effects.
radiation therapySome types of cancer are less resistant to radiation.

JCI MN Colloidal Iodine (C.I.M.N.) Excellence

  • Can kill only cancer cells
  • Does not harm normal cells. Rather, it activates them.
  • Fewer side effects (drug-related)
  • Not tolerant.
  • No accumulation in the body

As mentioned above, JCI MN colloidal iodine (C.I.M.N.) can kill only cancer cells, does not damage normal cells, and activates them. In addition, it has few side effects, is not tolerated, and does not accumulate in the body. On the other hand, cancer cells become resistant to anticancer drugs.

JCI MN Colloidal Iodine (C.I.M.N.) also does not accumulate in the body. Its duration of action in the body is 2 hours, after which it is eliminated from the body with urine. Therefore, it is advisable to take it every two hours, but it does not accumulate in the body and is safe.

On the other hand, depending on the type of anticancer drug, it takes about two years for it to be safely eliminated from the body.

Reactions during treatment
  • Various cancers including terminal cancer
  • Vascular disorders (brain, heart, etc.)
  • Autoimmune and allergic diseases
  • Viral diseases (including AIDS)
  • Epilepsy and other brain disorders
  • Diabetes mellitus, kidney disease
  • Other intractable diseases

JCI MN Colloidal Iodine (C.I.M.N) Dosing Method

Depending on the patient's medical condition, a combination of the following methods is used to administer the drug

-Internal use

JCI MN colloidal iodine (C.I.M.N.) is basically taken internally (30 ml/dose).

JCI MN colloidal iodine (C.I.M.N.) for oral use is available in two types: regular colloidal iodine oral solution and a prophylactic oral solution with a lower concentration for the prevention of disease or recurrence.

-Intravascular injection and infusion

Injections and infusions are particularly effective against leukemia and terminal cancers.

It is also suitable for patients with esophageal or gastric cancer who have difficulty with oral intake or who desire a short-term therapeutic effect.

-Inhalation

JCI MN colloidal iodine (C.I.M.N.) is atomized and inhaled using an inhaler. It is effective for patients with lung cancer and bronchial asthma.

In addition, the following methods are in the research phase
  • Intrapleural and intraperitoneal injections (pleural effusion, ascites)
  • Intrarectal (e.g., rectal cancer)
  • Intravaginal injection (cervical cancer)
  • Intravesical injection (bladder cancer)
  • local injection

For more information, please contact us here.

en_USEnglish